Please login to the form below
genomes
This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.
In plain sight
The researchers who raced to sequence the virus’ genome. The Chinese ophthalmologist who tried to warn his colleagues about this novel pneumonia in December 2019.
Latest news
-
Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal
GRN. In November, Lilly signed a deal with Precision BioSciences focused on genome editing research, with an initial focus on developing in vivo therapies for Duchenne muscular dystrophy and two other
-
Lilly links up with Precision BioSciences in genome editing deal
Precision will receive an upfront cash payment of $100m. Eli Lilly has shifted its focus to genome editing following a new research collaboration deal agreed with US-based specialist Precision BioSciences, ... Precision’s ARCUS genome editing platform
-
UCB boosts gene therapy offering with a pair of new deals
UCB paid $30m to access Element’s platform of technologies aimed at improving the understanding of genome structure and function – including CRISPR editing technologies used for genomic and epigenomic regulatory region
-
Covidian selection
Sometimes selection pressures work slowly, sometimes they work quickly. Daniel Lieberman’s excellent book, ‘The Story of the Human Body’ gives, for example, a fascinating description of how the human genome
-
Merck gets first approval for MET inhibitor tepotinib in Japan
The approval comes on the back of a phase 2 study – called VISION – which enrolled patients with METex14-positive NSCLC based on a just-approved companion diagnostic developed by genome analysis
More from news
Approximately 10 fully matching, plus 165 partially matching documents found.
Latest Intelligence
-
The promise of precision medicine
The Biobank’s broad data sets already cover deep phenotyping and whole genome sequencing from 20, 000 individuals, and the Qatar Genome Programme plans to sequence complete genomes of an additional ... treatment. The world- class Sidra Medicine
-
AI and accelerated computing ring in new era for healthcare
With genome analysis toolkits, researchers can sequence and analyse genomes up to 50x faster. ... Hundreds of institutions, including hospitals, universities and supercomputing centres across the world, are using this kind of software to accelerate their
-
Rare genetic diseases – what’s in store for 2021?
Why personalised medicine based on our own genomes is the future of healthcare. ... There have been numerous breakthroughs in recent years, which have made it clear that personalised medicine based on our very own genomes is the future of healthcare.
-
Switzerland: a life sciences hub
cells engineered to display chimeric antigen receptors) and genome editing (ie, CRISPR/Cas, TALEN, ZNF).
-
AI: the smart money is on the smart thinking
In the recent past, Qiagen also collaborated with Intel to find a solution that analyses human genomes for as little as $22, and the company has lately made headlines for being
More from intelligence
Approximately 1 fully matching, plus 39 partially matching documents found.
Latest appointments
-
Editas Medicine names James Mullen as chairman
He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.
-
Editas Medicine adds to its board of directors
Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.
-
Former GSK CEO joins Synthego’s advisory board
I look forward to contributing to the company’s success as the business extends further into the genome engineering market.”. ... Andrew’s appointment strengthens the company’s position as a leader in genome engineering solutions.”.
-
Paul Stockdale joins Oxford BioDynamics as CFO
A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.
-
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel
They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
The UK has become the first country to take Whole Genome Sequencing, a cutting-edge biotechnology, into mainstream healthcare. ... Rather than looking at the genetic makeup of just the 20, 000 genes known to cause disorders, the whole genome is analysed.
-
#DemandDiversity: The science behind diversity
3) Another study looked closely at publications that used data from the UK Biobank and the US Health and Retirement Study; these biobanks support genome-wide association studies, which scan data
-
#DemandDiversity: Names erased from history: A dive into black history of clinical research
For example, in all of the Genome-Wide Association Studies used to find mutations linked to cancer, over 80% of participants have been of European descent.
-
Understanding COVID-19 and varying responses across the globe
COVID-19, was first sequenced in Wuhan, China in January 2020. This helped us to identify novel regions of the genome allowing for the development of diagnostic assays to detect the ... As more testing occurs and more data is collected, understanding of
-
If our patients are diverse, why are clinical trials so white?
In 2009, almost all participants (96%) involved in genome-wide association studies (GWAS) were of European descent.
More from PMHub
Approximately 3 fully matching, plus 19 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Categories - Communiqué Awards
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- AZ sells stake in Moderna for around $1.2bn
- CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
- Building meaningful customer engagement through data-driven digital insights
- The role of women in science and technology
- Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
- CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Gene Editing and Precision Medicine: The Future of Healthcare?
PMHub
Bedrock Group
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
Quick links
Infographics
